Clinical Trial Update: Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a monoclonal antibody therapy in combination with interleukin-2 for metastatic melanoma (including intraocular melanoma an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Monoclonal antibody therapy (unspecified)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED